U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Natera

Market Cap: US$39.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Teva Pharmaceutical Industries

Market Cap: US$40.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Merck

Market Cap: US$316.1b

Operates as a healthcare company worldwide.

AbbVie

Market Cap: US$435.1b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Sotera Health

Market Cap: US$5.2b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

SIGA Technologies

Market Cap: US$232.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Mesa Laboratories

Market Cap: US$566.0m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Ligand Pharmaceuticals

Market Cap: US$6.0b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

BioLife Solutions

Market Cap: US$1.6b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.